Medtech covered by WTO provisions on IP (intellectual property) & public health
This article was originally published in Clinica
Executive Summary
Medical device companies that sell to the developing world could be affected by a landmark agreement at last week's global trade talks in Doha, Qatar, allowing poor nations to buy cheap generic versions of patented drugs.